TP53 and central nervous system cancer: Using a mouse model of TP53, PTEN and EGFR mutations in NSCs from the SVZ through genome editing, which were recurrent driver mutations found in the tumor-free SVZ tissues from the patients with GB, the early abnormal neural stem cell nests were induced in the subependymal zone, and glioma cells could be detected in multiple areas in the mouse brain.